Financial results of fiscal 2023 Net sales decrease organically by 1.6% to € 21.0 billion EBITDA pre down organically by 9.0% to € ...
The Change Healthcare Ransomware Payment Change Healthcare, a key player in the medical services sector owned by UnitedHealth Group, fell victim t...
MHTC has made significant strides in advancing agency-wide operational excellence which has been crucial to strengthening its foundation and positioning th...
Expands Viatris' Portfolio of Innovative Assets by Immediately Adding Two Phase 3 Assets, Selato...
- Biktarvy Now First and Only INSTI-Based Single-Tablet Regimen That is FDA Approved and DHHS Guideline Recommended for People Who are Virologically ...
Bitterroot Bio, a leader in innovative treatments for cardiovascular diseases, and Biotheus, a pioneer in monoclonal and multi-specific antibody design, an...
Approval based primarily on results from Phase 3 trial showing Dupixent significantly reduced itch compared to placebo CSU is the fifth approved...
The expansion into Silicon Valley marks a strategic move for Ajinomoto Co., which seeks to support and collaborate with innovators across four key growth a...
Boston Imaging, the U.S. headquarters of Samsung’s digital radiography and ultrasound division, proudly announces the launch of the Samsung Ultrasoun...
Amit Chopra, a seasoned professional with a proven track record in leadership, commercial strategies, manufacturing, mergers and acquisitions, and innovati...
-DNAnexus, Inc., the provider of the Precision Health Data Cloud, and TMA Precision Health, a global health platform for rare diseases, announced a collabo...
Cleerly, the company working to create a new standard of care for the diagnosis of heart disease, announced the launch of Cleerly ISCHEMIA, which rec...
HistoSonics, , the manufacturer of the non-invasive Edison® Histotripsy System, announced a patient from the University of Rochester Medical Cent...
QIAGEN to open regional headquarters in Riyadh, Saudi Arabia, at the beginning of 2024 to support growing presence in the region QIAGEN signed Memor...
© 2024 Biopharma Boardroom. All Rights Reserved.
